Interview

  • Interview: The US company appealing Europe’s rejection of daily Alzheimer’s pill

    Interview: The US company appealing Europe’s rejection of daily Alzheimer’s pill

    Despite having its application for a new, daily Alzheimer’s pill rejected by Europe’s regulators the CEO of US drug company Anavex Life Sciences is appealing this decision. A Phase IIb/III trial  found over one-third of patients with mild Alzheimer’s - those with a Mini-Mental State Examination (MMSE) score of between 20 and 28 - experienced [...]